Pomalidomide and Renal impairment - a phase IV clinical study of FDA data
Summary:
Renal impairment is reported as a side effect among people who take Pomalidomide (pomalidomide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Dexamethasone, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Renal impairment when taking Pomalidomide. It is created by eHealthMe based on reports of 14,524 people who have side effects when taking Pomalidomide from the FDA, and is updated regularly.
What is Pomalidomide?
Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.
What is Renal impairment?
Renal impairment (severely reduced kidney function) is found to be associated with 2,208 drugs and 2,470 conditions by eHealthMe. Check the latest studies of Renal impairment.
14,524 people reported to have side effects when taking Pomalidomide.
Among them, 88 people (0.61%) have Renal impairment.

Among these 88 people:
How long have people been on Pomalidomide when they have Renal impairment? *
- < 1 month: 76.19 %
- 1 - 6 months: 14.29 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 4.76 %
- 2 - 5 years: 4.76 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Renal impairment when taking Pomalidomide? *
- female: 17.81 %
- male: 82.19 %
What is the age of people who have Renal impairment when taking Pomalidomide? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 22.86 %
- 60+: 77.14 %
What are other drugs people take besides Pomalidomide? *
- Dexamethasone: 43 people, 48.86%
- Lenalidomide: 25 people, 28.41%
- Thalidomide: 20 people, 22.73%
- Bortezomib: 18 people, 20.45%
- Melphalan: 11 people, 12.50%
- Cyclophosphamide: 8 people, 9.09%
- Dexamethasone Sodium Phosphate: 7 people, 7.95%
- Darzalex: 6 people, 6.82%
- Velcade: 6 people, 6.82%
- Carfilzomib: 6 people, 6.82%
What are other side effects people have besides Renal impairment? *
- Multiple Myeloma (cancer of the plasma cells): 19 people, 21.59%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 14 people, 15.91%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 11 people, 12.50%
- Thrombocytopenia (decrease of platelets in blood): 10 people, 11.36%
- Anaemia (lack of blood): 9 people, 10.23%
- Bk Virus Infection: 7 people, 7.95%
- Death: 7 people, 7.95%
- Polyomavirus-Associated Nephropathy (polyomavirus-associated kidney disease): 7 people, 7.95%
- Nausea And Vomiting: 7 people, 7.95%
- Back Pain: 6 people, 6.82%
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 64 people, 72.73%
- Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 4 people, 4.55%
- Pain: 3 people, 3.41%
- Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 3 people, 3.41%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 2.27%
- Cardiac Failure: 2 people, 2.27%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 2.27%
- Diabetes: 2 people, 2.27%
- Diarrhea: 1 person, 1.14%
- Amyloidosis (a tumour within which amyloid is produced): 1 person, 1.14%
* Approximation only. Some reports may have incomplete information.
Do you take Pomalidomide and have Renal impairment?
- Check whether Renal impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Pomalidomide:
- Pomalidomide (14,524 reports)
Renal impairment treatments and more:
- Renal impairment (99,633 reports)
How severe was Renal impairment and when was it recovered:
Expand to all the drugs that have ingredients of pomalidomide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pomalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Renal impairment:
- Renal impairment (2,209 drugs)
Browse all the conditions that are associated with Renal impairment:
- Renal impairment (2,470 conditions)
Related publications that referenced our studies
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on pomalidomide (the active ingredients of Pomalidomide) and Pomalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zejula cause Pollakiuria? - 25 seconds ago
- How effective is Meloxicam for Sciatica? - 36 seconds ago
- Could Lunesta cause Consciousness - Decreased? - a minute ago
- Farxiga vs. Amaryl, side effect and effectiveness comparison - a minute ago
- Drug interactions of Pyrazinamide and Sertraline - a minute ago
- Drug interactions of Aloe Vera and Centrum - a minute ago
- Could Paxil cause Abdominal Mass? - a minute ago
- Drug interactions of Pyridoxal Phosphate and Quetiapine Fumarate - a minute ago
- Drug interactions of Prochlorperazine Maleate and Exidine - a minute ago
- Could Finasteride cause Blood Urine Present? - a minute ago